Diagnostic Significance of PSA Density Adjusted by Transition Zone Volume in Males with PSA Levels between 2 and 4 ng/ml

European Urology

Volumn 45, Issue 1, 2004, Pages 92-97

  Ohi, Masaru ^a   Ito, Kazuto ^a   Suzuki, Kazuhiro ^a   Yamamoto, Takumi ^a   Yamanaka, Hidetoshi ^a   Djavan, B ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Prostate cancer; Prostate volume; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT INDICATION;

EID: 0346118848     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.07.001     Document Type: Article

References (18)

1. A.W Partin L.A Mangold D.M Lamm P.C Walsh J.I Epstein J.D Pearson Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 2001 843 848
2. R.J Babaian D.A Johnston W Naccarato A Ayala V.A Bhadkamkar H.A Fritsche Jr. The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy J. Urol. 165 2001 757 760
3. W.J Catalona A.W Partin J.A Finlay D.W Chan H.G Rittenhouse R.L Wolfert Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/ml and digital rectal examination is not suspicious for prostate cancer: an alternative model Urology 54 1999 220 224
4. W.J Catalona D.S Smith D.K Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of specificity with free PSA measurements JAMA 277 1997 1452 1455
5. K Ito T Yamamoto Y Kubota K Suzuki Y Fukabori K Kurokawa Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer Urology 56 2000 278 282
6. R Raaijmakers B Blijenberg H.G Rittenhouse M.A Roobol J.A Finlay F.H Schröder Prostate cancer (PC) detection in the PSA range 2–3 ng/ml—value of PSA, FPSA, HK2 and related algorithms J. Urol. 167 Suppl 2002 286
7. W Horninger H Volgger H Rogatsch A Gschwendtner G Bartsch Consideration of low PSA cut-off levels to optimize the detection of curable prostate cancer Eur. Urol. 39 Suppl. 4 2001 43 46
8. Ries LAG, Kosary CL, Hankey BF, et al., editors. SEER Cancer Statistics Review, 1973–1995. Bethesda, MD: National Cancer Institute; 1998.
9. F.H Schröder I van der Cruijsen-Koeter H.J de Koning A.N Vis R.F Hoedemaeker R Kranse Prostate cancer detection at low prostate specific antigen J. Urol. 163 2000 806 812
10. K Ito Y Kubota K Suzuki N Shimizu Y Fukabori K Kurokawa Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations Urology 55 2000 705 709
11. T Yamamoto K Ito M Ohi Y Kubota K Suzuki Y Fukabori Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/ml or less Urology 58 2001 994 998
12. J Kalish W.H Cooner S.D Graham Jr. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate Urology 43 1994 601 606
13. B Djavan A.R Zlotta M Remzi K Ghawidel B Bursa S Hruby Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Urology 54 1999 846 852
14. E Kikuchi J Nakashima M Ishibashi T Ohigashi H Asakura M Tachibana Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma Cancer 89 2000 842 849
15. A.R Zlotta B Djavan M Petein M Susani M Marberger C.C Schulman Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng/ml J. Urol. 160 1998 2089 2095
16. B Djavan A Zlotta C Kratzik M Remzi C Seitz C.C Schulman PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml Urology 54 1999 517 522
17. B Djavan A.R Zlotta M Remzi K Ghawidel B Bursa S Hruby Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Urology 54 1999 846 852
18. B Djavan A Zlotta C Kratzik M Remzi C Seitz C.C Schulman PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml Urology 54 1999 517 522